UW Carbone Cancer Center receives ‘outstanding’ rating from National Cancer Institute
National Cancer Institute reviewers found that the UW Carbone Cancer Center’s six program areas were rated 'outstanding' or 'outstanding to exceptional'....
National Cancer Institute reviewers found that the UW Carbone Cancer Center’s six program areas were rated 'outstanding' or 'outstanding to exceptional'....
Predictive analytics, the use of data, algorithms and visualizations to forecast outcomes, is being increasingly used in drug development and clinical trial design....
The NIH explores ways to speed up the research and discovery of new treatments for rare diseases, which are not often thought of as the public health challenge that they are. ...
Following a year filled with several approvals for rare disease drugs, experts are expecting this trend to continue in 2023....
The FDA recently released guidance related to clinical research on human drugs containing cannabis or cannabis-derived compounds....
Exploring ways clinical trial leaders and organizers can improve the patient experience....
Experts share why protection by the exclusion of pregnant people leads to a lack of evidence-based medicine and ways to improve clinical trial conduct....
The pandemic exposed existing clinical trial limitations and improved trial design by increasing focus on the prime subject of research, the patient....
Technology that streamlines processes, provides transparency into clinical operations and enables robust data collection will empower sponsors to more rapidly enroll clinical studies and to study medicines in the diverse populations which they will serve. ...
Doing more to acknowledge the important role of clinical trials participants could help with recruitment....